HSPD1 and neoplasm: Xenograft studies using WT and Hsp60+/– DU145 cells demonstrated that deletion of one allele of Hsp60 (i.e., Hsp60+/– DU145 xenograft) greatly reduced tumor burden, inhibited tumor incidence, and was accompanied by ClpP downregulation (Figure 5, A–C).